stella
beta
Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study — Stella
Home
/
Atherosclerotic Vascular Disease
/
View on ClinicalTrials.gov
Recruiting
Back to Atherosclerotic Vascular Disease trials
Trial locations
(20 sites)
Spain
Novartis Investigative Site, Cadiz, Andalusia
Novartis Investigative Site, Granada, Andalusia
Novartis Investigative Site, Huelva, Andalusia
Novartis Investigative Site, Jaén, Andalusia
Novartis Investigative Site, Marbella, Andalusia
Novartis Investigative Site, Mallorca, Balearic Islands
Novartis Investigative Site, Puerto Real, Cadiz
Novartis Investigative Site, Santander, Cantabria
Novartis Investigative Site, Andújar, Jaen
Novartis Investigative Site, Logroño, La Rioja
Novartis Investigative Site, San Cristóbal de La Laguna, Santa Cruz De Tenerife
Novartis Investigative Site, Burgos
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Fuerteventura
Novartis Investigative Site, Las Palmas GC
Novartis Investigative Site, León
Novartis Investigative Site, Málaga
Novartis Investigative Site, Salamanca
Novartis Investigative Site, Seville
Novartis Investigative Site, Seville